PT  - JOURNAL ARTICLE
AU  - Priya Kannian
AU  - Chandra Lavanya
AU  - Krittika Ravichandran
AU  - Bagavad Gita Jayaraman
AU  - Pasuvaraj Mahanathi
AU  - Veeraraghavan Ashwini
AU  - Nagalingeswaran Kumarasamy
AU  - Gunaseelan Rajan
AU  - Kannan Ranganathan
AU  - Stephen J. Challacombe
AU  - Jennifer Webster-Cyriaque
AU  - Newell W. Johnson
TI  - Detection of SARS-CoV2 antigen in human saliva may be a reliable tool for large scale screening
AID  - 10.1101/2020.12.17.20248437
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.17.20248437
4099  - http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248437.short
4100  - http://medrxiv.org/content/early/2020/12/19/2020.12.17.20248437.full
AB  - Introduction SARS-CoV2, the aetiological agent of the current COVID-19 pandemic, has been detected in saliva and recently implicated in several oral diseases. Collection of nasopharyngeal swabs (NPS) and detection by reverse transcriptase-polymerase chain reaction (RT-PCR) requires medical / technical expertise. A reliable and easy to handle point-of-care (POC) test is highly desirable, especially to curb transmission. Therefore, in this study, we evaluated a commercially available POC rapid antigen test (RAT) for the detection of SARS-CoV2 antigens in the saliva of RT-PCR confirmed positive and negative patients.Methods Thirty saliva samples of 10 saliva RT-PCR negative and 20 saliva RT-PCR positive patients were tested by RAT.Results RAT was negative in 10/10 (100%) RT-PCR-negative samples; positive in 9/20 (45%) RT-PCR-positive samples; concordance was 63% (p=0.001). Patients with positive RAT had higher virus copies in their NPS samples compared to the RAT-negative patients. This difference was also statistically significant (p=0.01).Conclusion Thus, the POC RAT may be used to detect SARS-CoV2 as a reliable tool for self-testing, large-scale population screening and emergency medical/dental screening. Patients negative by RAT should be confirmed by RT-PCR.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is not a clinical trial.Funding StatementThis work was funded by intramural research funds of Chennai Dental Research Foundation, Chennai, India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the VHS-Institutional Ethics Committee (proposal #: VHS-IEC/69-2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data pertinent to the manuscript has been uploaded with the manuscript files.AbbreviationsSARS-CoV2severe acute respiratory syndrome – coronavirus 2COVID-19coronavirus disease 2019RT-PCRreverse transcriptase-polymerase chain reactionNPSnasopharyngeal swabPOCpoint-of-careRATrapid antigen testACE-2angiotensin converting enzyme-2ICMRIndian Council of Medical Research